Profile data is unavailable for this security.
About the company
Coegin Pharma AB, formerly GoldBlue AB (publ) is a Sweden-based biotechnology company. The Company focuses on the development of small molecule therapies aimed at the key enzyme, which is known for its involvement in a variety of inflammatory diseases as well as in cancer. Coegin Pharma AB provides consulting and management services in drug development as well.
- Revenue in SEK (TTM)0.00
- Net income in SEK-27.98m
- Incorporated2016
- Employees0.00
- LocationCoegin Pharma ABc/o Medicon VillageLUND 223 81SwedenSWE
- Phone+46 855925266
- Websitehttps://coeginpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spago Nanomedical AB (publ) | 1.47m | -35.58m | 101.67m | 12.00 | -- | 1.91 | -- | 69.35 | -0.3129 | -0.3129 | 0.0113 | 0.1525 | 0.0324 | -- | 9.91 | 112,769.20 | -78.60 | -20.19 | -93.27 | -20.97 | -5.25 | -- | -2,426.88 | -4,853.45 | -- | -- | 0.00 | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| Alzinova AB | 300.00k | -17.17m | 106.68m | 5.00 | -- | 0.6513 | -- | 355.61 | -0.3221 | -0.3221 | 0.0056 | 1.98 | 0.0027 | -- | 0.4459 | 60,000.00 | -15.32 | -10.77 | -16.22 | -11.27 | 6,018.45 | -- | -5,723.82 | -18,447.90 | -- | -- | 0.0073 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -136.81m | 109.30m | 16.00 | -- | 0.7357 | -- | -- | -0.3953 | -0.3953 | 0.00 | 0.2488 | 0.00 | -- | -- | 0.00 | -64.42 | -- | -84.94 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -13.84 | -- |
| Xintela AB | 377.00k | -49.24m | 151.96m | -- | -- | -- | -- | 403.07 | -0.1217 | -0.1217 | 0.0008 | -0.0136 | 0.0193 | -- | 0.0447 | -- | -252.59 | -181.06 | -- | -391.61 | 100.00 | -- | -13,061.54 | -235,894.00 | -- | -49.47 | -- | -- | -- | -45.54 | 18.32 | -- | -61.47 | -- |
| Coegin Pharma AB | 0.00 | -27.98m | 168.85m | 0.00 | -- | 12.96 | -- | -- | -2.65 | -2.65 | 0.00 | 0.6403 | 0.00 | -- | -- | -- | -125.24 | -122.02 | -201.53 | -154.70 | -- | -- | -- | -28,466.75 | -- | -170.65 | 0.00 | -- | -- | -- | 20.60 | -- | -- | -- |
| AlzeCure Pharma AB | 0.00 | -37.43m | 172.19m | 11.00 | -- | 9.43 | -- | -- | -0.5685 | -0.5685 | 0.00 | 0.2122 | 0.00 | -- | -- | 0.00 | -92.80 | -52.78 | -115.25 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -44.80m | 175.26m | 8.00 | -- | 8.72 | -- | -- | -0.1651 | -0.1651 | 0.00 | 0.0556 | 0.00 | -- | -- | -- | -122.57 | -57.97 | -179.56 | -97.83 | -- | -- | -- | -1,454.61 | -- | -- | 0.1145 | -- | -- | -- | 21.54 | -- | -- | -- |
| Kancera AB | 0.00 | -60.35m | 196.81m | 5.00 | -- | 2.10 | -- | -- | -0.7267 | -0.7267 | 0.00 | 0.7749 | 0.00 | -- | -- | 0.00 | -52.92 | -54.82 | -65.84 | -66.21 | -- | 96.28 | -- | -7,249.06 | -- | -- | 0.00 | -- | -- | -- | -23.64 | -- | -- | -- |
| Biovica International AB | 7.29m | -124.82m | 202.24m | 32.00 | -- | 2.26 | -- | 27.74 | -2.12 | -2.12 | 0.1218 | 1.15 | 0.048 | 0.2322 | 6.50 | 227,843.80 | -82.20 | -51.94 | -99.16 | -58.18 | 94.34 | 181.68 | -1,712.00 | -2,217.41 | 3.04 | -- | 0.0749 | -- | 115.49 | 19.39 | -12.97 | -- | -54.31 | -- |
| Abliva AB | 137.00k | -97.60m | 207.81m | 6.00 | -- | 3.08 | -- | 1,516.83 | -0.0924 | -0.0924 | 0.0001 | 0.05 | 0.0013 | -- | 0.0045 | -- | -88.80 | -74.59 | -96.20 | -86.98 | -21,359.13 | -- | -71,240.15 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| SenzaGen AB | -100.00bn | -100.00bn | 209.48m | 32.00 | -- | 2.62 | -- | -- | -- | -- | -- | 2.71 | -- | -- | -- | -- | -- | -25.84 | -- | -29.85 | -- | 68.62 | -- | -132.29 | 1.24 | -- | 0.0368 | -- | 19.39 | 90.32 | 11.30 | -- | -21.10 | -- |
| Exact Therapeutics AS | 0.00 | -48.03m | 213.59m | 8.00 | -- | 4.77 | -- | -- | -1.51 | -1.51 | 0.00 | 1.41 | 0.00 | -- | -- | -- | -67.21 | -40.21 | -86.14 | -45.67 | -- | -- | -- | -- | -- | -16,578.57 | 0.0258 | -- | -- | -- | -20.52 | -- | -- | -- |
| Acousort AB | 4.29m | -17.78m | 231.48m | -- | -- | 11.59 | -- | 53.91 | -1.25 | -1.25 | 0.3048 | 1.34 | 0.1595 | 4.59 | 4.21 | -- | -66.05 | -48.62 | -99.10 | -69.77 | -117.16 | -68.05 | -414.04 | -299.58 | 2.72 | -- | 0.00 | -- | 11.51 | 38.81 | -24.01 | -- | -- | -- |
| Intervacc AB | 8.93m | -102.77m | 236.30m | 15.00 | -- | 1.07 | -- | 26.47 | -1.40 | -1.40 | 0.1221 | 2.91 | 0.0365 | 3.25 | 1.55 | 595,066.70 | -41.96 | -17.62 | -45.32 | -18.77 | -589.11 | -243.59 | -1,151.30 | -626.90 | 4.33 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
Data as of Jul 05 2024. Currency figures normalised to Coegin Pharma AB's reporting currency: Swedish Krona SEK
